<p>, /PRNewswire/ -- Bronstein, Gewirtz &amp; Grossman, LLC，一家全國知名的投資者權益律師事務所，宣佈已對 Ardent Health, Inc. (NYSE: ARDT) 及其部分高管提起集體訴訟。</p>
<p>本訴訟旨在代表所有在 2024 年 7 月 18 日至 2025 年 11 月 12 日期間（包括這兩個日期）購買或以其他方式獲得 Ardent 證券的個人和實體，追討因被告涉嫌違反聯邦證券法而造成的損失。鼓勵這些投資者通過訪問該事務所網站加入此案：bgandg.com/ARDT。</p>
<p><strong>Ardent 案件詳情</strong></p>
<p>投訴書指控被告在整個集體訴訟期間作出了實質性虛假和誤導性陳述，和/或未能披露以下內容：</p>
<p>(1) Ardent Health 2025 年第三季度的收入因在公司轉向新的收入會計系統後對應收賬款可收回性判斷不充分而被誇大，並且 “最近完成的歷史收款趨勢回顧評估” 也未能反映真實情況；</p>
<p>(2) 公司的 2025 年 EBITDA 指導被誇大，預計在中間值上將減少 5750 萬美元，約 9.6%，原因是 “持續的行業成本壓力”，包括 “付款方拒絕”；以及</p>
<p>(3) 因此，被告關於公司業務、運營和前景的陳述在所有相關時間都是實質性虛假和誤導的，和/或缺乏合理依據。</p>
<p><strong>Ardent 投資者接下來該怎麼辦？</strong></p>
<p>集體訴訟已被提起。如果您希望查看投訴書的副本，可以訪問該事務所網站：bgandg.com/ARDT。或者您可以聯繫 Bronstein, Gewirtz &amp; Grossman, LLC 的 Peretz Bronstein 律師或其客户關係經理 Nathan Miller，電話：917-590-0911。如果您在 Ardent 中遭受損失，您有直到 2026 年 3 月 9 日的時間請求法院任命您為首席原告。您分享任何賠償的能力並不要求您擔任首席原告。</p>
<p><strong>對 Ardent 投資者沒有費用</strong></p>
<p>我們，Bronstein, Gewirtz &amp; Grossman LLC，以風險代理的方式代表投資者進行集體訴訟。這意味着只有在我們成功的情況下，我們才會要求法院報銷我們的實際支出和律師費，通常是總賠償金額的一定比例。</p>
<p><strong>為什麼選擇 Bronstein, Gewirtz &amp; Grossman, LLC 進行 Ardent 證券集體訴訟？</strong></p>
<p>Bronstein, Gewirtz &amp; Grossman, LLC 是一家全國知名的律師事務所，代表投資者進行證券欺詐集體訴訟和股東派生訴訟。我們的事務所為全國投資者追回了數億美元的賠償。更多信息請訪問 www.bgandg.com</p>
<p>“我們的業務重點是恢復投資者資本並確保企業問責制，這有助於維護市場的基本誠信，” Bronstein, Gewirtz &amp; Grossman, LLC 的創始合夥人 Peretz Bronstein 説道。</p>
<p>請在 LinkedIn、X、Facebook 或 Instagram 上關注我們以獲取更新。</p>
<p><strong>聯繫方式</strong></p>
<p>Peretz Bronstein 律師或 Nathan Miller</p>
<p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
<p>917-590-0911 | [email protected]</p>
<p>律師廣告。</p>
<p>以往的結果並不保證類似的結果。</p>
<p>來源：Bronstein, Gewirtz &amp; Grossman, LLC</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTEyJk5ld3NJdGVtSWQ9REM2MDIyNiZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTIxMjAwUFJfTkVXU19VU1BSX19fX19EQzYwMjI2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTEyJk5ld3NJdGVtSWQ9REM2MDIyNiZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTIxMjAwUFJfTkVXU19VU1BSX19fX19EQzYwMjI2"/></p>

ARDT

<p>Bronstein, Gewirtz & Grossman, LLC 已代表在 2024 年 7 月 18 日至 2025 年 11 月 12 日期間購買證券的投資者對 Ardent Health, Inc.（紐約證券交易所代碼：ARDT）提起集體訴訟。訴訟指控 Ardent 對其財務表現做出了虛假陳述，包括誇大了收入和 EBITDA 指引。鼓勵投資者加入此案，並可以聯繫該公司獲取更多信息。該公司以風險代理費用的方式運營，這意味着投資者無需支付前期費用</p>

<p>, /PRNewswire/ -- Bronstein, Gewirtz &amp; Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) and certain of its officers.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Bronstein, Gewirtz &amp; Grossman, LLC，一家全國知名的投資者權益律師事務所，宣佈已對 Ardent Health, Inc. (NYSE: ARDT) 及其部分高管提起集體訴訟。</p>
</div><p>This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ardent securities between July 18, 2024 and November 12, 2025, both dates inclusive (the &#34;Class Period&#34;). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/ARDT.</p>
<div class="lb-trans"><p>本訴訟旨在代表所有在 2024 年 7 月 18 日至 2025 年 11 月 12 日期間（包括這兩個日期）購買或以其他方式獲得 Ardent 證券的個人和實體，追討因被告涉嫌違反聯邦證券法而造成的損失。鼓勵這些投資者通過訪問該事務所網站加入此案：bgandg.com/ARDT。</p>
</div><p><strong>Ardent Case Details</strong></p>
<div class="lb-trans"><p><strong>Ardent 案件詳情</strong></p>
</div><p>The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:</p>
<div class="lb-trans"><p>投訴書指控被告在整個集體訴訟期間作出了實質性虛假和誤導性陳述，和/或未能披露以下內容：</p>
</div><p>(1) Ardent Health's third quarter 2025 revenue was overstated due to inadequate determinations of accounts receivable collectability following the Company's transition to a new revenue accounting system and &#34;recently completed hindsight evaluations of historical collection trends&#34;;</p>
<div class="lb-trans"><p>(1) Ardent Health 2025 年第三季度的收入因在公司轉向新的收入會計系統後對應收賬款可收回性判斷不充分而被誇大，並且 “最近完成的歷史收款趨勢回顧評估” 也未能反映真實情況；</p>
</div><p>(2) the Company's 2025 EBITDA guidance was overstated and would be reduced by $57.5 million at the midpoint, or approximately 9.6%, due to &#34;persistent industry-wide cost pressures,&#34; including &#34;payer denials&#34;; and</p>
<div class="lb-trans"><p>(2) 公司的 2025 年 EBITDA 指導被誇大，預計在中間值上將減少 5750 萬美元，約 9.6%，原因是 “持續的行業成本壓力”，包括 “付款方拒絕”；以及</p>
</div><p>(3) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.</p>
<div class="lb-trans"><p>(3) 因此，被告關於公司業務、運營和前景的陳述在所有相關時間都是實質性虛假和誤導的，和/或缺乏合理依據。</p>
</div><p><strong>What's Next for Ardent Investors?</strong></p>
<div class="lb-trans"><p><strong>Ardent 投資者接下來該怎麼辦？</strong></p>
</div><p>A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/ARDT. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz &amp; Grossman, LLC at 917-590-0911. If you suffered a loss in Ardent you have until March 9, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.</p>
<div class="lb-trans"><p>集體訴訟已被提起。如果您希望查看投訴書的副本，可以訪問該事務所網站：bgandg.com/ARDT。或者您可以聯繫 Bronstein, Gewirtz &amp; Grossman, LLC 的 Peretz Bronstein 律師或其客户關係經理 Nathan Miller，電話：917-590-0911。如果您在 Ardent 中遭受損失，您有直到 2026 年 3 月 9 日的時間請求法院任命您為首席原告。您分享任何賠償的能力並不要求您擔任首席原告。</p>
</div><p><strong>No Cost to Ardent Investors</strong></p>
<div class="lb-trans"><p><strong>對 Ardent 投資者沒有費用</strong></p>
</div><p>We, Bronstein, Gewirtz &amp; Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.</p>
<div class="lb-trans"><p>我們，Bronstein, Gewirtz &amp; Grossman LLC，以風險代理的方式代表投資者進行集體訴訟。這意味着只有在我們成功的情況下，我們才會要求法院報銷我們的實際支出和律師費，通常是總賠償金額的一定比例。</p>
</div><p><strong>Why Bronstein, Gewirtz &amp; Grossman, LLC for Ardent Securities Class Action?</strong></p>
<div class="lb-trans"><p><strong>為什麼選擇 Bronstein, Gewirtz &amp; Grossman, LLC 進行 Ardent 證券集體訴訟？</strong></p>
</div><p>Bronstein, Gewirtz &amp; Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com</p>
<div class="lb-trans"><p>Bronstein, Gewirtz &amp; Grossman, LLC 是一家全國知名的律師事務所，代表投資者進行證券欺詐集體訴訟和股東派生訴訟。我們的事務所為全國投資者追回了數億美元的賠償。更多信息請訪問 www.bgandg.com</p>
</div><p>&#34;Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace,&#34; said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz &amp; Grossman, LLC.</p>
<div class="lb-trans"><p>“我們的業務重點是恢復投資者資本並確保企業問責制，這有助於維護市場的基本誠信，” Bronstein, Gewirtz &amp; Grossman, LLC 的創始合夥人 Peretz Bronstein 説道。</p>
</div><p>Follow us for updates on LinkedIn, X, Facebook, or Instagram.</p>
<div class="lb-trans"><p>請在 LinkedIn、X、Facebook 或 Instagram 上關注我們以獲取更新。</p>
</div><p><strong>Contact Info</strong></p>
<div class="lb-trans"><p><strong>聯繫方式</strong></p>
</div><p>Peretz Bronstein, Esq. or Nathan Miller</p>
<div class="lb-trans"><p>Peretz Bronstein 律師或 Nathan Miller</p>
</div><p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
<div class="lb-trans"><p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
</div><p>917-590-0911 | [email protected]</p>
<div class="lb-trans"><p>917-590-0911 | [email protected]</p>
</div><p>Attorney advertising.</p>
<div class="lb-trans"><p>律師廣告。</p>
</div><p>Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p>以往的結果並不保證類似的結果。</p>
</div><p>SOURCE Bronstein, Gewirtz &amp; Grossman, LLC</p>
<div class="lb-trans"><p>來源：Bronstein, Gewirtz &amp; Grossman, LLC</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTEyJk5ld3NJdGVtSWQ9REM2MDIyNiZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTIxMjAwUFJfTkVXU19VU1BSX19fX19EQzYwMjI2" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC60226&amp;Transmission_Id=202601121200PR_NEWS_USPR_____DC60226&amp;DateId=20260112"/></p>

Bronstein, Gewirtz & Grossman LLC 敦促 Ardent Health, Inc.的投資者採取行動：已提起集體訴訟，指控投資者受到損害